// App-Quantinova.ai

: Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing ILDs treated with DMARDs or glucocorticoids?

Researchers

Presenter

  • Nazia Chaudhuri

Principal Investigators

  • Vincent Cottin

  • Stefania Cerri

  • Michael Kreuter

  • Maria Otaola

  • Diego Castillo Villegas

  • Craig Glazer

  • Heiko Müller

  • Carl Coeck

  • Manuel Quaresma

  • Toby M Maher

Medical Centers

  • North West Interstitial Lung Disease Unit, Manchester University Foundation Trust, Wythenshawe, Manchester, United Kingdom

  • National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France,

  • Center for Rare Lung Disease - Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy

  • Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany,

  • Fundación para el Estudio de Enfermedades Fibrosantes del Pulmón, Buenos Aires, Argentina

  • Department of Respiratory Medicine, Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, United States of America

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • SCS Boehringer Ingelheim Comm. V., Brussels, Belgium

  • National Heart and Lung Institute, Imperial College London, UK and National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK, London, United Kingdom

Locations

  • United Kingdom

  • France

  • Italy

  • Germany

  • Argentina

  • Spain

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved